Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Europe Markets
  • China Markets
  • Asia Markets
  • World Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
  • Europe Politics
  • China Politics
  • Asia Politics
  • World Politics
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Top Video
  • Live Audio
  • Europe TV
  • Asia TV
  • CNBC Podcasts
  • CEO Interviews
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Business News

Health and Science

  • Coronavirus
  • Biotech and Pharma
  • Health Insurance
  • Hospitals
  • Science
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Angelica Peebles3 hours ago
Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug
Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug
Elsa OhlenWed, Jun 3rd 2026
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial
Angelica PeeblesSun, May 31st 2026
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
Brandon GomezMon, Jun 1st 2026
Replimune to resubmit twice rejected drug for approval after FDA shakeup
Replimune to resubmit twice rejected drug for approval after FDA shakeup
Angelica PeeblesFri, May 29th 2026
Oura is launching its smallest smart ring yet, shrinking wearable design by 40%
CNBC Disruptor 50
Oura is launching its smallest smart ring yet, shrinking wearable design by 40%
Thu, May 28th 2026
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
Health and Science
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
Thu, May 28th 2026
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder
Tech
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder
Wed, May 27th 2026

Trending Now

  • 1
    Sellers are pulling homes off the market at the fastest pace since 2020
  • 2
    SpaceX targets fixed $135 IPO roadshow price at $1.75 trillion valuation, source says
  • 3
    Dow falls 400 points as oil prices and bond yields creep higher: Live updates
  • 4
    Trump says Iran agreed to not have nuclear weapons, but 'they can change their mind'
  • 5
    Trump Accounts create a 'legal backdoor' for Roth IRA wealth, tax attorney says

More In Health and Science

Trump officials hit California with Medicaid funding freeze
Healthy Returns
Trump officials hit California with Medicaid funding freeze
Wed, May 27th 2026
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know
Healthy Returns
Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know
Wed, May 27th 2026
Signos grows foothold in weight-loss wave fueled by GLP-1s with AI tracking
Tech
Signos grows foothold in weight-loss wave fueled by GLP-1s with AI tracking
Fri, May 29th 2026
Health and Science
How one medical supply CEO is navigating the oil price shock
Tue, May 26th 2026
Health and Science
Eli Lilly says next-generation weight loss drug clears crucial obesity trial
Thu, May 21st 2026
CNBC Cures
Cavs owner Dan Gilbert turns grief over son’s rare disease into search for cure
Thu, May 28th 2026
Eli Lilly accuses church bishops, businessmen of fraud in drug rebate scheme
Health and Science
Eli Lilly accuses church bishops, businessmen of fraud in drug rebate scheme
Thu, May 21st 2026
Trump says he's 'concerned' about Ebola after American tests positive in Africa
Politics
Trump says he's 'concerned' about Ebola after American tests positive in Africa
Mon, May 18th 2026
White House adds generic drugs to direct-to-consumer TrumpRx site
Health and Science
White House adds generic drugs to direct-to-consumer TrumpRx site
Mon, May 18th 2026
Health and Science
CDC says American tests positive for Ebola in Africa, risk in U.S. remains low
Mon, May 18th 2026
Health and Science
FDA shuffles top drug, biologics leaders in latest leadership shakeup
Tue, May 19th 2026
Health and Science
Bristol Myers Squibb turns to China to develop new drugs
Tue, May 19th 2026
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Health and Science
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Thu, May 14th 2026
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Health and Science
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Thu, May 14th 2026
Hantavirus isn't another Covid, but experts say it's testing U.S. readiness
Health and Science
Hantavirus isn't another Covid, but experts say it's testing U.S. readiness
Thu, May 14th 2026
Health and Science
Trump says Makary resigns as FDA commissioner following backlash
Tue, May 12th 2026
Healthy Returns
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients
Tue, May 12th 2026
Mad Money
Jim Cramer says today’s market is punishing stocks harder than 1999
Mon, May 11th 2026
Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile
Pharmaceuticals
Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile
Mon, May 11th 2026
Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk
The Bottom Line
Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk
Sat, May 9th 2026
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Health and Science
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Fri, May 8th 2026
Healthy Returns
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada
Thu, May 7th 2026
Life
Planet Fitness stock plunges 30% after company slashes guidance
Thu, May 7th 2026
Inside Wealth
Family office deal-making rebounds in April with healthcare bets
Thu, May 7th 2026
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Join the CNBC Panel
  • Digital Products
  • News Releases
  • Closed Captioning
  • Corrections
  • About CNBC
  • Internships
  • Site Map
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo